Factor VII polypeptide variant, nucleic acid construct, recombinant host cell, transgenic animal, method of producing factor VII polypeptide variant, pharmaceutical composition and use of factor VII polypeptide variant
The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as nucleic acid constructs encoding such variants, vectors and host cells comprising and expressing the nucleic acid, pharmaceutical compositions, uses and methods of treatment.